Portfolio
Regional leaders,national ambitions.
Our portfolio of leading regional healthcare companies across resilient, tailwind-driven end markets.
Vital Care Infusion Services
Franchised infusion pharmacy network with more than 35 years of history, delivering home and alternate-site infusion therapy through locally owned pharmacies. Albaron's platform operates four pharmacies across Tennessee, Kentucky, New Jersey, and Ohio, with eight total sites of care.
IR MSO
Multi-site interventional radiology platform operating through office-based labs, formed in 2025 via Albaron's partnership with one of the nation's leading interventional radiologists.
Innovation Fertility
National network of leading IVF clinics and embryology laboratories - built through acquisitions including RMA of Michigan and SpringCreek Fertility - that partners with practices on lab operations, technology, and management while preserving physician autonomy.
Metro Vein Centers
Leading network of vein treatment clinics with 67 locations across eight states, including New York, New Jersey, Texas, Michigan, Arizona, and Connecticut.
Prime Psychiatry
Texas-based psychiatry platform with locations in Austin, Frisco, Plano, and Southlake - offering evaluations, medication management, TMS, Spravato, and telepsychiatry, founded by quadruple board-certified psychiatrist Dr. Efosa Airuehia.
Beyond Podiatry
The Midwest's leading podiatry platform - 56 doctors across 30+ locations in five states treating 250,000+ patients a year. Sold to CUC Inc. (TSE: 9158) in 2024 at an $87 million valuation: the first private equity exit in U.S. podiatry.
MedTech for Solutions
Services company for ART/IVF practices, providing embryology laboratory management, specialized temporary staffing, and practice development to fertility providers in the US and internationally.
Companies Backed
Successful Exits
Transactions
Realized - Case Study
Revenue quadrupledin three years.
Albaron partnered with founder Dr. Stephen Frascone to scale Beyond Podiatry into a multi-site platform - quadrupling revenue in three years and completing a successful exit.